{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:06:11Z","timestamp":1778259971465,"version":"3.51.4"},"reference-count":63,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2020,12,15]]},"DOI":"10.1167\/tvst.9.13.21","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T17:27:44Z","timestamp":1608053264000},"page":"21","source":"Crossref","is-referenced-by-count":24,"title":["Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium\/Choroid in Rabbits"],"prefix":"10.1167","volume":"9","author":[{"given":"Viral S.","family":"Kansara","sequence":"first","affiliation":[{"name":"Clearside Biomedical, Inc., Alpharetta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Cooper","sequence":"additional","affiliation":[{"name":"Copernicus Therapeutics, Inc., Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Sesenoglu-Laird","sequence":"additional","affiliation":[{"name":"Copernicus Therapeutics, Inc., Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leroy","family":"Muya","sequence":"additional","affiliation":[{"name":"Clearside Biomedical, Inc., Alpharetta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Moen","sequence":"additional","affiliation":[{"name":"Copernicus Therapeutics, Inc., Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Ciulla","sequence":"additional","affiliation":[{"name":"Clearside Biomedical, Inc., Alpharetta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"issue":"R1","key":"bib2","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1093\/hmg\/ddz130","article-title":"Has retinal gene therapy come of age? From bench to bedside and back to bench","volume":"28","author":"Trapani","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"1","key":"bib3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","article-title":"Gene therapy for inherited retinal and optic nerve degenerations","volume":"18","author":"Moore","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"bib4","first-page":"69","article-title":"Gene therapy: the next frontier for treatment of acquired and inherited ocular disorders","author":"Seidman","year":"2015","journal-title":"Retina Today"},{"issue":"10","key":"bib5","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1080\/14712598.2017.1356817","article-title":"Gene therapy for age-related macular degeneration","volume":"17","author":"Moore","year":"2017","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"bib6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2006","journal-title":"Hum Gene Ther"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2017.02.018","article-title":"Gene therapy in neovascular age-related macular degeneration: three-year follow-up of a phase 1 randomized dose escalation trial","volume":"177","author":"Constable","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"bib9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/sj.gt.3302761","article-title":"Plasmid size up to 20?kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles","volume":"13","author":"Fink","year":"2006","journal-title":"Gene Ther"},{"issue":"pt B","key":"bib10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejpb.2014.12.028","article-title":"Nanoparticle-based technologies for retinal gene therapy","volume":"95","author":"Adijanto","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/mt.2011.196","article-title":"Optimization of hCFTR lung expression in mice using DNA nanoparticles","volume":"20","author":"Padegimas","year":"2012","journal-title":"Mol Ther"},{"issue":"12","key":"bib12","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/hum.2004.15.1255","article-title":"Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution","volume":"15","author":"Konstan","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"10","key":"bib13","doi-asserted-by":"publisher","first-page":"e7410","DOI":"10.1371\/journal.pone.0007410","article-title":"Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina","volume":"4","author":"Ding","year":"2009","journal-title":"PLoS One"},{"issue":"6","key":"bib14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ymthe.2003.09.002","article-title":"Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung","volume":"8","author":"Ziady","year":"2003","journal-title":"Mol Ther"},{"issue":"5","key":"bib15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2310\/7290.2010.00053","article-title":"DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging","volume":"10","author":"Yurek","year":"2011","journal-title":"Mol Imaging"},{"issue":"6","key":"bib16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1021\/mp0600034","article-title":"Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy","volume":"3","author":"Walsh","year":"2006","journal-title":"Mol Pharm"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1016\/j.ymthe.2006.08.459","article-title":"Compacted DNA nanoparticles transfect cells by binding to cell surface nucleolin","volume":"13","author":"Chen","year":"2006","journal-title":"Mol Ther"},{"key":"bib18","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/S1525-0016(16)44714-3","article-title":"Intracellular trafficking of DNA nanoparticle and nucleolin antibody","volume":"15","author":"Chen","year":"2007","journal-title":"Mol Ther"},{"issue":"4","key":"bib19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1096\/fsb2.v24.4","article-title":"Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa","volume":"24","author":"Cai","year":"2010","journal-title":"FASEB J"},{"issue":"4","key":"bib20","doi-asserted-by":"publisher","first-page":"e5290","DOI":"10.1371\/journal.pone.0005290","article-title":"A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles","volume":"4","author":"Cai","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"bib21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2217\/nnm.11.158","article-title":"Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity","volume":"7","author":"Han","year":"2012","journal-title":"Nanomedicine"},{"issue":"35","key":"bib22","doi-asserted-by":"publisher","first-page":"9483","DOI":"10.1016\/j.biomaterials.2011.08.062","article-title":"Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells","volume":"32","author":"Koirala","year":"2011","journal-title":"Biomaterials"},{"issue":"12","key":"bib23","doi-asserted-by":"publisher","first-page":"e52189","DOI":"10.1371\/journal.pone.0052189","article-title":"Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"key":"bib24","first-page":"36","article-title":"Retinal gene therapies in clinical trials\u2014a proliferation of clinical trials means hope for patients","volume":"16","author":"Kay","year":"2019","journal-title":"Retina Physician"},{"issue":"9","key":"bib25","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 gene therapy for X-linked retinoschisis: initial findings from a phase I\/IIa trial by intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol Ther"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"bib27","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/aos.2019.97.issue-5","article-title":"Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach","volume":"97","author":"Habot-Wilner","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"bib29","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1172\/JCI129085","article-title":"AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression","volume":"129","author":"Ding","year":"2019","journal-title":"J Clin Invest"},{"issue":"27","key":"bib30","doi-asserted-by":"publisher","first-page":"eaba1606","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci Adv"},{"issue":"7","key":"bib31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"bib32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/jop.2019.0126","article-title":"Suprachoroidal delivery of viral and nonviral gene therapy for retinal diseases","volume":"36","author":"Kansara","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"35","key":"bib34","doi-asserted-by":"publisher","first-page":"32578","DOI":"10.1074\/jbc.M305776200","article-title":"Nanoparticles of compacted DNA transfect postmitotic cells","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"bib35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ymthe.2003.07.007","article-title":"Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo","volume":"8","author":"Ziady","year":"2003","journal-title":"Mol Ther"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp Eye Res"},{"issue":"2","key":"bib37","doi-asserted-by":"publisher","first-page":"e17140","DOI":"10.1371\/journal.pone.0017140","article-title":"Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter","volume":"6","author":"Peden","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"bib39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hgtb.2013.212","article-title":"Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A","volume":"25","author":"Dyka","year":"2014","journal-title":"Hum Gene Ther Methods"},{"issue":"5","key":"bib40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/hum.2018.156","article-title":"An AAV dual vector strategy ameliorates the Stargardt phenotype in adult Abca4(\u2013\/\u2013) mice","volume":"30","author":"McClements","year":"2019","journal-title":"Hum Gene Ther"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3389\/fnins.2017.00503","article-title":"Evaluating efficiencies of dual AAV approaches for retinal targeting","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front Neurosci"},{"issue":"2","key":"bib42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol Ther"},{"issue":"1","key":"bib43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2384-2-14","article-title":"Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability","volume":"2","author":"Sarin","year":"2010","journal-title":"J Angiogenes Res"},{"issue":"6","key":"bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/jcs.112.6.761","article-title":"Structure and functions of nucleolin","volume":"112","author":"Ginisty","year":"1999","journal-title":"J Cell Sci"},{"issue":"1","key":"bib45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/mt.2010.214","article-title":"Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid","volume":"19","author":"Chen","year":"2011","journal-title":"Mol Ther"},{"issue":"5","key":"bib46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.preteyeres.2010.04.004","article-title":"Nanoparticles for retinal gene therapy","volume":"29","author":"Conley","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"bib47","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.mt.6300365","article-title":"Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA","volume":"16","author":"Chen","year":"2008","journal-title":"Mol Ther"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"119961","DOI":"10.1016\/j.biomaterials.2020.119961","article-title":"Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: a push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy","volume":"243","author":"Luo","year":"2020","journal-title":"Biomaterials"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"126190","DOI":"10.1016\/j.cej.2020.126190","article-title":"Multifunctional glutathione-dependent hydrogel eye drops with enhanced drug bioavailability for glaucoma therapy","volume":"402","author":"Lai","year":"2020","journal-title":"Chem Eng J"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.actbio.2020.04.055","article-title":"Effects of shell thickness of hollow poly(lactic acid) nanoparticles on sustained drug delivery for pharmacological treatment of glaucoma","volume":"111","author":"Nguyen","year":"2020","journal-title":"Acta Biomater"},{"issue":"9","key":"bib51","first-page":"1914","article-title":"Gene transfer with liposomes to the intraocular tissues by different routes of administration","volume":"37","author":"Masuda","year":"1996","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"21","key":"bib52","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/sj.gt.3302579","article-title":"Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity","volume":"12","author":"Marano","year":"2005","journal-title":"Gene Ther"},{"issue":"3","key":"bib53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2144\/000112404","article-title":"In vivo gene delivery in the retina using polyethylenimine","volume":"42","author":"Liao","year":"2007","journal-title":"Biotechniques"},{"issue":"4","key":"bib54","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/jphp.12104","article-title":"Dendrimers for gene delivery\u2013a potential approach for ocular therapy?","volume":"66","author":"Chaplot","year":"2014","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"bib55","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1167\/iovs.02-1068","article-title":"Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles","volume":"44","author":"Bourges","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"bib56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/gt.2009.158","article-title":"Inhibitory efficacy of hypoxia-inducible factor 1alpha short hairpin RNA plasmid DNA-loaded poly (D, L-lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model","volume":"17","author":"Zhang","year":"2010","journal-title":"Gene Ther"},{"issue":"1","key":"bib57","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pone.0000038","article-title":"Efficient non-viral ocular gene transfer with compacted DNA nanoparticles","volume":"1","author":"Farjo","year":"2006","journal-title":"PLoS One"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"S359","DOI":"10.1006\/mthe.2001.0269","article-title":"Type of polylysine counterion influences morphology and biological function of condensed DNA","volume":"3","author":"Kowalczyk","year":"2001","journal-title":"Mol Ther."},{"issue":"1","key":"bib60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12886-016-0181-9","article-title":"Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"bib61","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1167\/iovs.15-16597","article-title":"Real-time monitoring of suprachoroidal space (SCS) following SCS injection using ultra-high resolution optical coherence tomography in guinea pig eyes","volume":"56","author":"Gu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1167\/iovs.16-20377","article-title":"Thickness and closure kinetics of the suprachoroidal space following microneedle injection of liquid formulations","volume":"58","author":"Chiang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.actbio.2016.03.036","article-title":"Quantification of cellular and nuclear uptake rates of polymeric gene delivery nanoparticles and DNA plasmids via flow cytometry","volume":"37","author":"Bishop","year":"2016","journal-title":"Acta Biomater"},{"key":"bib1"},{"key":"bib8"},{"key":"bib38","first-page":"557","article-title":"Ophthalmic toxicology and assessing ocular irritation","volume-title":"Derma Toxicology","author":"Hackett","year":"1996","edition":"5th ed."},{"key":"bib58","article-title":"United States Patent 8,017,577.","author":"Cooper","year":"2011"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T03:20:30Z","timestamp":1670210430000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":63,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.13.21","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,15]]}}}